The content management platform developer more than trebled its valuation to over $3bn in a round featuring Tidemark.

MicroPort's implantable implantable defibrillator and pacemaker spinoff has secured funding in a series C round co-led by its parent company.

Novo led the sustainable materials producer’s series C round, three years after a round backed by investors including Ginkgo Bioworks.

SoftBank Vision Fund 2 has led a round that took the Salesforce Ventures-backed online classroom tool provider's overall funding to more than $160m.

UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.

PsiQuantum has become the first unicorn in Imec.xpand’s portfolio as it fetched a valuation of more than $3bn.

IP Group is among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.

Microsoft and Munich Re helped the cybersecurity insurance platform developer complete a series D round which took its overall funding to $272m.

M Ventures, Novartis Venture Fund and Pfizer Ventures are among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.

The Salesforce-backed digital marketing technology provider received the cash in a round led by B Capital Group that brought its overall funding past the $350m mark.